Business Context and Reporting Period
This Form 6-K filing by Dr. Reddy's Laboratories Limited, dated November 1, 2002, discloses a material change in shareholding. The report addresses the acquisition of shares by the Life Insurance Corporation of India (LIC) as of October 18, 2002, pursuant to SEBI (Substantial Acquisition of Shares and Takeover) Regulations, 1997.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a regulatory disclosure regarding equity ownership rather than a financial performance report.
Material Changes
- Shareholding Threshold: The Life Insurance Corporation of India acquired shares and voting rights that, when combined with existing holdings, exceeded the 5% threshold of the company's paid-up capital.
- Ownership Stake: As of October 18, 2002, LIC held 4,225,522 shares, representing 5.52% of the paid-up capital.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. The document is strictly a notification of a substantial acquisition of shares required under Indian securities regulations.
Investor Verification Checklist
- Verify the total paid-up capital of Dr. Reddy's Laboratories to confirm the 5.52% stake calculation.
- Review subsequent filings to determine if LIC's stake increased beyond the initial 5.52% disclosure.
- Check the company's annual report (Form 20-F) for the full financial performance metrics absent in this filing.